FI20021762A0 - Uusia terapeuttisia aineita ja valmisteita - Google Patents

Uusia terapeuttisia aineita ja valmisteita

Info

Publication number
FI20021762A0
FI20021762A0 FI20021762A FI20021762A FI20021762A0 FI 20021762 A0 FI20021762 A0 FI 20021762A0 FI 20021762 A FI20021762 A FI 20021762A FI 20021762 A FI20021762 A FI 20021762A FI 20021762 A0 FI20021762 A0 FI 20021762A0
Authority
FI
Finland
Prior art keywords
preparations
new therapeutic
therapeutic substances
substances
new
Prior art date
Application number
FI20021762A
Other languages
English (en)
Swedish (sv)
Inventor
Merja Auvinen
Mathias Bergman
Hannu Elo
Original Assignee
Karyon Oy Ab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karyon Oy Ab Ltd filed Critical Karyon Oy Ab Ltd
Priority to FI20021762A priority Critical patent/FI20021762A0/fi
Publication of FI20021762A0 publication Critical patent/FI20021762A0/fi
Priority to CNA2003801048277A priority patent/CN1720258A/zh
Priority to PCT/FI2003/000726 priority patent/WO2004031221A1/en
Priority to AU2003267476A priority patent/AU2003267476A1/en
Priority to US10/530,024 priority patent/US20060275213A1/en
Priority to CA002500833A priority patent/CA2500833A1/en
Priority to EP03748163A priority patent/EP1549669A1/en
Priority to JP2004540845A priority patent/JP2006517907A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI20021762A 2002-10-03 2002-10-03 Uusia terapeuttisia aineita ja valmisteita FI20021762A0 (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20021762A FI20021762A0 (fi) 2002-10-03 2002-10-03 Uusia terapeuttisia aineita ja valmisteita
CNA2003801048277A CN1720258A (zh) 2002-10-03 2003-10-03 肿瘤靶向剂及其应用
PCT/FI2003/000726 WO2004031221A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof
AU2003267476A AU2003267476A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof
US10/530,024 US20060275213A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof
CA002500833A CA2500833A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof
EP03748163A EP1549669A1 (en) 2002-10-03 2003-10-03 Tumor targeting agents and uses thereof
JP2004540845A JP2006517907A (ja) 2002-10-03 2003-10-03 腫瘍標的化剤及びその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20021762A FI20021762A0 (fi) 2002-10-03 2002-10-03 Uusia terapeuttisia aineita ja valmisteita

Publications (1)

Publication Number Publication Date
FI20021762A0 true FI20021762A0 (fi) 2002-10-03

Family

ID=8564695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021762A FI20021762A0 (fi) 2002-10-03 2002-10-03 Uusia terapeuttisia aineita ja valmisteita

Country Status (8)

Country Link
US (1) US20060275213A1 (fi)
EP (1) EP1549669A1 (fi)
JP (1) JP2006517907A (fi)
CN (1) CN1720258A (fi)
AU (1) AU2003267476A1 (fi)
CA (1) CA2500833A1 (fi)
FI (1) FI20021762A0 (fi)
WO (1) WO2004031221A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130202652A1 (en) * 2010-07-30 2013-08-08 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
WO2016172187A1 (en) * 2015-04-20 2016-10-27 H. Lee Moffitt Cancer Center And Research Institute, Inc. Methods and compositions related to kras inhibitors
US11278521B2 (en) 2015-12-15 2022-03-22 University Of South Florida GAS5 binding compounds, formulations, and uses thereof
CN107987127B (zh) * 2017-06-08 2020-09-15 中山大学附属肿瘤医院 整合素α6靶向多肽及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271041A3 (en) * 1986-12-10 1990-04-11 Abbott Laboratories Atrial peptide derivatives
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
DK0885242T3 (da) * 1995-06-07 2008-07-14 Glaxo Group Ltd Peptider og forbindelser, der binder til en trombopoietinreceptor
US5622699A (en) * 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore

Also Published As

Publication number Publication date
CN1720258A (zh) 2006-01-11
EP1549669A1 (en) 2005-07-06
JP2006517907A (ja) 2006-08-03
AU2003267476A1 (en) 2004-04-23
US20060275213A1 (en) 2006-12-07
WO2004031221A1 (en) 2004-04-15
CA2500833A1 (en) 2004-04-15
WO2004031221A9 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
NO20033556D0 (no) Farmasöytiske preparater
PT1501534E (pt) Formulacoes farmaceuticas
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
SE0203190L (sv) Anordning och förfarande
NO20055652D0 (no) Laktatinneholdende farmasoytisk preparat og anvendelse av dette
IS7571A (is) Ný lífeðlisfræðilega virk efni
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20044916L (no) Preparater av sulfinylacetamid
SE0301997L (sv) Anordning och förfarande
NO20050689L (no) Terapeutisk anvendelse
NO20043576L (no) Pharmaceutical formulation comprising melatonin
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
FI20021762A0 (fi) Uusia terapeuttisia aineita ja valmisteita
FI20021617A0 (fi) Diagnostisia ja terapeuttisia menetelmiä
FI20031927A0 (fi) Terapeuttisesti vaikuttavia aineita ja niiden käyttö
FI20021763A0 (fi) Uusia terapeuttisesti aktiivisia aineita ja niiden käyttö
FI20021760A0 (fi) Uusia terapeuttisia/diagnostisia aineita ja valmisteita sovellutuksineen
FI20030871A0 (fi) Terapeuttisesti vaikuttavat aineet ja niiden käyttö
FI20021761A0 (fi) Uusia lääkeaineita ja -valmisteita sekä niiden käyttö
FI20031797A (fi) Uusia radiolääkkeitä ja diagnostisia valmisteita
FI20031920A0 (fi) Uusia radiolääkkeitä ja diagnostisia valmisteita
NO20043749L (no) Stabilt farmasoytisk preparat omfattende torsemidmodifikasjon II